Menorrhagia: Drug Therapy

Therapeutic target

The primary goal is to clarify the prolonged and increased bleeding, and to treat the underlying condition.

Normalization of the duration and strength of menstrual bleeding.

Therapy recommendations

  • During sexual maturity, if necessary, by administration of hormones (ovulation inhibitors: birth control pills), change in hormone therapy, removal of intrauterine device (“IUD”) if necessary, preoperative (“before surgery”) therapyof fibroids (benign growths in the muscular layer of the uterus; see hypermenorrhea/excessive menstrual bleeding).
  • Perimenopause (transitional phase between premenopause and postmenopause; different lengths of years before menopause/time of the last spontaneous menstruation in the life of a woman – about five years – and after menopause, 1 year) if necessary by hormone administration (estrogen + progestin/monophasic or sequential; transdermal (“through the skin“) estrogen-progestin combinations for sequential application or for use without bleeding), change of hormone therapy, discontinuation of hormone therapy.